Silk Road Medical
Total Raised
$160.6MInvestors Count
6Deal Terms
5Funding, Valuation & Revenue
10 Fundings
Silk Road Medical has raised $160.6M over 10 rounds.
Silk Road Medical's latest funding round was a Acq - P2P for on September 17, 2024.
Silk Road Medical's valuation in April 2019 was $604.16M.
Silk Road Medical's latest post-money valuation is from September 2024.
Sign up for a free demo to see Silk Road Medical's valuations in September 2024 and more.
Silk Road Medical's 2018 revenue was $34.64M. Silk Road Medical's most recent revenue is from 2018.
Sign up for a free demo to see revenue data from 2019 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
9/17/2024 | Acq - P2P | 12 | ||||
4/4/2019 | IPO | $120M | $604.16M | 4 | ||
7/18/2017 | Series E | $47M | CRG, Janus Capital Group, Norwest Venture Partners, The Vertical Group, and Warburg Pincus | $34.64M (7.68x) FY 2018 | 2 | |
10/20/2015 | Debt | |||||
10/20/2015 | Series D |
Date | 9/17/2024 | 4/4/2019 | 7/18/2017 | 10/20/2015 | 10/20/2015 |
|---|---|---|---|---|---|
Round | Acq - P2P | IPO | Series E | Debt | Series D |
Amount | $120M | $47M | |||
Investors | CRG, Janus Capital Group, Norwest Venture Partners, The Vertical Group, and Warburg Pincus | ||||
Valuation | $604.16M | ||||
Revenue | $34.64M (7.68x) FY 2018 | ||||
Sources | 12 | 4 | 2 |
Silk Road Medical Deal Terms
5 Deal Terms
Silk Road Medical's deal structure is available for 5 funding rounds, including their Acq - P2P from September 17, 2024.
Round | Acq - P2P | IPO | Series E | Series B | Series A |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - P2P | |||||||||||||||
IPO | |||||||||||||||
Series E | |||||||||||||||
Series B | |||||||||||||||
Series A |
Silk Road Medical Investors
6 Investors
Silk Road Medical has 6 investors. Boston Scientific invested in Silk Road Medical's Acq - P2P funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
9/17/2024 | 9/17/2024 | 1 Acq - P2P | Corporation | Massachusetts | ||
Venture Capital | New Jersey | |||||
Private Equity | New York | |||||
Debt & Specialty Finance | Texas | |||||
Venture Capital | California |
First funding | 9/17/2024 | ||||
|---|---|---|---|---|---|
Last Funding | 9/17/2024 | ||||
Investor | |||||
Rounds | 1 Acq - P2P | ||||
Board Seats | |||||
Type | Corporation | Venture Capital | Private Equity | Debt & Specialty Finance | Venture Capital |
Location | Massachusetts | New Jersey | New York | Texas | California |
Compare Silk Road Medical to Competitors
Quasar is a high-quality medical devices manufacturing company specializing in minimally invasive devices, catheters, and sensors. The company offers a full lifecycle of engineering services, including design, prototyping, complex assembly, and full device assembly, ensuring efficiency and productivity in the medical device sector. Quasar primarily serves the healthcare sector, providing turnkey solutions to medical device companies. It was founded in 1988 and is based in Yokneam Ilit, Israel.
Sahajanand Medical Technologies (SMT) develops and manufactures in the medical device industry, focusing on minimally invasive cardiovascular devices. The company offers a range of products, including coronary stents, balloon catheters, and inflation devices designed to support various treatments. SMT's portfolio includes biodegradable polymer-based drug-eluting stents and other treatment solutions. It was founded in 1998 and is based in Surat, India.
Translumina is a company that develops and manufactures interventional cardiovascular devices, specializing in drug-eluting stents, drug-eluting balloons, and PTCA balloons. These products are aimed at the cardiovascular medical sector. The company serves the healthcare industry with a focus on medical device technology and innovation. It was founded in 2000 and is based in Hechingen, Germany.
China Medical Device operates in the medical device sector, primarily involved in the manufacturing and distribution of medical equipment and healthcare products. It was founded in 1966 and is based in Chaoyang District, China.
Shanghai Kinetic Co., Ltd. is a medical device manufacturer focused on orthopedics, cardiovascular, and sports medicine. The company provides a variety of medical devices for the treatment of medical conditions. Shanghai Kinetic serves hospitals and medical professionals. It was founded in 2005 and is based in Shanghai, Shanghai.
BridgePoint Medical is focused on developing technology in the field of interventional cardiology for access to and treatment of chronic total occlusions. In September 2012, BridgePoint medical was acquired by Boston Scientific. The valuation of BridgePoint Medical was undisclosed. Other terms of the deal were not released.
Loading...